Studies have demonstrated that the expression levels of hepcidin and ferroportin in the tissue samples of pancreatic cancer patients undergoing radical surgery are highly expressed in pancreatic cancer tissues. The gene discussed is SLC40A1; the disease is familial pancreatic carcinoma.